Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||||
---|---|---|---|---|---|---|---|---|
Fig. 7 b
Balashova OA et al. (2024) |
Xla Wt + cd2ap MO1
NF15-17 (western blot) |
|
||||||
Fig. 4 a
Balashova OA et al. (2024) |
Xla Wt + folr1 MO
NF15-17 (western blot) |
|
||||||
Fig 3 I
Zhang Z et al. (2016) |
Xla Wt + sdc4 MO
NF19 (western blot) |
|
||||||
fig.5.a
Wang S et al. (2013) |
Xla Wt + pard6b MO
NF12 (immunohistochemistry) |
|
||||||
Fig 4 C C^1
Wang S et al. (2013) |
Xla Wt + pard6b MO
NF15 (immunohistochemistry) |
|
||||||
fig.5.a
Wang S et al. (2013) |
Xla Wt + pard6b MO
NF16 (immunohistochemistry) |
|
||||||
fig.5.a
Wang S et al. (2013) |
Xla Wt + pard6b MO
NF19 (immunohistochemistry) |
|
||||||
fig.3.d
Zhang Z et al. (2013) |
Xla Wt + fzd7 MO
NF20 (immunohistochemistry) |
|
||||||
fig.S2.a^1, a^2
Ninomiya H et al. (2012) |
Xla Wt + cdh3
NF10.5 (immunohistochemistry) |
|
||||||
fig.S2.b^1, b^2
Ninomiya H et al. (2012) |
Xla Wt + cdh3 MO
NF10.5 (immunohistochemistry) |
|